441 related articles for article (PubMed ID: 24880702)
1. Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus.
Tsunekuni R; Hikono H; Saito T
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):184-91. PubMed ID: 24880702
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Avian Paramyxovirus Serotypes 2, 6, and 10 as Vaccine Vectors for Highly Pathogenic Avian Influenza in Chickens with Antibodies Against Newcastle Disease Virus.
Tsunekuni R; Hikono H; Tanikawa T; Kurata R; Nakaya T; Saito T
Avian Dis; 2017 Sep; 61(3):296-306. PubMed ID: 28957006
[TBL] [Abstract][Full Text] [Related]
3. Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1).
Nayak B; Dias FM; Kumar S; Paldurai A; Collins PL; Samal SK
Vaccine; 2012 Mar; 30(12):2220-7. PubMed ID: 22222870
[TBL] [Abstract][Full Text] [Related]
4. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.
Kumar S; Nayak B; Collins PL; Samal SK
J Virol; 2011 Jul; 85(13):6521-34. PubMed ID: 21525340
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken.
Yang W; Dai J; Liu J; Guo M; Liu X; Hu S; Gu M; Hu J; Hu Z; Gao R; Liu K; Chen Y; Liu X; Wang X
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632659
[TBL] [Abstract][Full Text] [Related]
7. Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
Hu Z; Liu X; Jiao X; Liu X
Vaccine; 2017 Dec; 35(48 Pt B):6585-6590. PubMed ID: 29042201
[TBL] [Abstract][Full Text] [Related]
8. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
9. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
Kim SH; Paldurai A; Samal SK
Virology; 2017 Mar; 503():31-36. PubMed ID: 28110247
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
Liu J; Xue L; Hu S; Cheng H; Deng Y; Hu Z; Wang X; Liu X
Arch Virol; 2018 Dec; 163(12):3365-3371. PubMed ID: 30187143
[TBL] [Abstract][Full Text] [Related]
11. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
Kim SH; Samal SK
Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
[TBL] [Abstract][Full Text] [Related]
12. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
[TBL] [Abstract][Full Text] [Related]
13. Immune responses of poultry to Newcastle disease virus.
Kapczynski DR; Afonso CL; Miller PJ
Dev Comp Immunol; 2013 Nov; 41(3):447-53. PubMed ID: 23623955
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
[TBL] [Abstract][Full Text] [Related]
16. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
18. Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease.
Grund C; Steglich C; Huthmann E; Beer M; Mettenleiter TC; Römer-Oberdörfer A
Virol J; 2014 Oct; 11():179. PubMed ID: 25297904
[TBL] [Abstract][Full Text] [Related]
19. Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens.
Shirvani E; Samal SK
Viruses; 2020 Jun; 12(7):. PubMed ID: 32605292
[TBL] [Abstract][Full Text] [Related]
20. A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.
Shirvani E; Varghese BP; Paldurai A; Samal SK
Sci Rep; 2020 Feb; 10(1):2221. PubMed ID: 32042001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
